NCT00555074View on ClinicalTrials.gov

Sodium Tungstate in Obesity

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Obesity
Interventions
DRUG

Sodium Tungstate

Sodium Tungstate, 200 mg BID, oral route during 6 weeks

DRUG

Placebo

Placebo, BID, oral route during 6 weeks

Trial Locations (1)

08036

Hospiral Clinic de Barcelona, Barcelona

All Listed Sponsors
collaborator

Fundacio Clinic Barcelona

OTHER

lead

Hospital Clinic of Barcelona

OTHER

NCT00555074 - Sodium Tungstate in Obesity | Biotech Hunter | Biotech Hunter